HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells.

Abstract
In response to infection or immunization, antibodies are produced that provide protection against re-exposure with the same pathogen. These antibodies can persist at high titers for decades and are maintained by bone marrow-resident long-lived plasma cells (LLPC). However, the durability of antibody responses to immunization varies amongst vaccines. It is unknown what factors contribute to the differential longevity of serum antibody responses and whether heterogeneity in LLPC contributes to this phenomenon. While LLPC differentiation has been studied extensively in mice, little is known about this population in humans or non-human primates (NHP). Here, we use multi-omic single-cell profiling to identify and characterize the LLPC compartment in NHP. We identify LLPC biomarkers including the marker CD102 and show that CD102 in combination with CD31 identifies LLPC in NHP bone marrow. Additionally, we find that CD102 is expressed by LLPC in mouse and humans. These results further our understanding of the LLPC compartment in NHP, identify biomarkers of LLPC, and provide tissue-specific single cell references for future studies.
AuthorsRyan P Staupe, Kenneth E Lodge, Nithya Thambi, David Toole, Alex M Tamburino, Dan Chang, Bonnie J Howell, Daria J Hazuda, Kalpit A Vora, Nicole L Sullivan
JournalCommunications biology (Commun Biol) Vol. 5 Issue 1 Pg. 1399 (12 21 2022) ISSN: 2399-3642 [Electronic] England
PMID36543997 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. Merck & Co., Inc., Rahway, NJ, USA and its affiliates.
Chemical References
  • Antibodies
  • Biomarkers
Topics
  • Mice
  • Animals
  • Plasma Cells
  • Multiomics
  • Antibody Formation
  • Antibodies
  • Primates
  • Biomarkers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: